Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2019 February;71(1) > Minerva Ginecologica 2019 February;71(1):25-35

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  INNOVATIONS IN GYNECOLOGY AND OBSTETRICS 

Minerva Ginecologica 2019 February;71(1):25-35

DOI: 10.23736/S0026-4784.18.04337-X

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Sentinel node biopsy for treatment of endometrial cancer: current perspectives

Andrea PAPADIA 1 , Maria L. GASPARRI 1, 2, Junjie WANG 1, 3, Anda P. RADAN 1, Michael D. MUELLER 1

1 Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, Bern, Switzerland; 2 Department of Gynecology and Obstetrics, Sapienza University, Rome, Italy; 3 Department of Gynecological Oncology, KK Women’s and Children’s Hospital, Singapore, Singapore



The risk of lymph nodal metastases in endometrial cancer varies greatly according to the characteristics of the primary tumor. Surgical staging with a systematic lymphadenectomy in endometrial cancer is debated since three decades. On one hand, it provides important pathological information on the spread of the tumor allowing for an appropriate decision making on adjuvant treatment but on the other side it is characterized by a non-negligible short and long-term morbidity. In the past decade, various efforts have been made in the attempt to apply the concept of the sentinel lymph node mapping in endometrial cancer. The sentinel lymph node mapping has the potential to provide the necessary pathological lymph nodal information at a reasonable cost in terms of morbidity. In this review, the most relevant aspects of the sentinel lymph node mapping in endometrial cancer are summarized. Furthermore, the performance in terms of false negative rates and detection rates, the clinical value of the pathological ultrastaging, its clinical applicability in different scenarios including patients preoperatively considered to be at low or at high risk are discussed. Oncological outcome of the patients who have been submitted to a sentinel lymph node mapping as compared to a full lymhadenectomy are presented as well as technical aspects to improve the performance of the surgical technique.


KEY WORDS: Endometrial neoplasms - Sentinel lymph node - Lymph node excision - Indocyanine green - Technetium

top of page